Serum concentrations of rifampin, isoniazid, and intestinal absorption, permeability in patients with multidrug resistant tuberculosis. 2009

Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
Clinical Research Unit and Institute of Biomedicine/Center for Global Health, Department of Physiology and Pharmacology, School of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. ybarroso@fortalnet.com.br

This study evaluates the serum concentrations of rifampin (RMP), isoniazid (INH), and intestinal barrier function in patients with multidrug-resistant tuberculosis (MDR-TB), drug susceptible tuberculosis (DS-TB), and health volunteers (HC; controls). Peak serum concentrations of RMP were significantly lower in MDR-TB and DS-TB as compared with HC (odds ratio [OR] = 3.125, confidence interval [CI] [1.037-9.418] and OR = 4.025, CI [1.207-13.418], respectively). The INH peak serum concentration was not significantly different between MDR-TB versus DS-TB or DS-TB versus HC. The percent of mannitol excretion was significantly lower in the MDR-TB group compared with DS-TB (13.18 versus 16.03, analysis of covariance [ANCOVA], P = 0.0369) and compared with HC (13.18 versus 16.61, ANCOVA, P = 0.0291) the other study groups. These data suggested a lower peak serum concentration of RMP for both MDR-TB and DS-TB as compared with the HC group. The data also showed a lower intestinal area of absorption in patients with tuberculosis and even worse in MDR-TB.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
January 2022, PloS one,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
March 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
February 1993, The New England journal of medicine,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
February 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
November 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
November 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
December 2010, Journal of clinical microbiology,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
September 2017, Microbial pathogenesis,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
November 2013, Antimicrobial agents and chemotherapy,
Elizabeth C Barroso, and Valéria G F Pinheiro, and Mônica C Façanha, and Maria R D Carvalho, and Maria E Moura, and Creusa L Campelo, and Charles A Peloquin, and Richard L Guerrant, and Aldo A M Lima
June 1958, Pediatrics,
Copied contents to your clipboard!